GIA™ vs. Cogstate
Game-based cognitive testing was built for clinical trials. Conversational multimodal screening was built for clinical care.
Cogstate offers computerized cognitive assessment through game-based testing, where patients interact with digital card games and pattern recognition tasks on a tablet or computer. Cogstate has established itself in clinical trial settings, providing standardized cognitive endpoints for pharmaceutical research. Their assessments typically take 15–20 minutes and focus on cognitive domains like attention, learning, and working memory. GIA™ takes a fundamentally different approach. Instead of asking patients to play computer games, GIA™ conducts a natural conversation lasting under 5 minutes. During that conversation, GIA™ analyzes 2,500+ Speech Biomarkers and 436 visual data points to screen for 46 conditions across cognitive, behavioral, and neurological health. No game interface. No test anxiety. Just a conversation that writes clinical data back to the EHR.
How do they compare?
| Dimension | Cogstate | GIA™ |
|---|---|---|
| Assessment method | Game-based computer tasks | Natural conversation with Digital Human® |
| Screening time | 15–20 minutes | Under 5 minutes |
| Conditions assessed | Cognitive domains only | 46 conditions: cognitive, behavioral, neurological |
| Patient interaction | Digital card games on tablet/computer | Conversational speech via video, voice, or landline |
| Speech biomarkers | None | 2,500+ per conversation |
| Visual biomarkers | None | 436 data points per session |
| Primary market | Clinical trials (based on available information) | Post-acute and long-term clinical care |
| Staff requirement | Supervision typically needed | Zero during screening. Clinician reviews results. |
| EHR write-back | Based on available information, varies by deployment | Real-time: results, notes, transcript, video |
| Practice effects | Present. Repeated game exposure affects scores | None. Natural conversation does not produce practice effects |
Where cogstate falls short
A computerized cognitive assessment company offering game-based testing for clinical trials and clinical care. Patients complete digital card games and pattern recognition tasks to measure cognitive domains including attention, learning, working memory, and psychomotor speed.
- Cognitive assessment only. Does not screen for depression, anxiety, PTSD, Parkinson’s, substance abuse, or other behavioral and neurological conditions
- Game-based testing requires patient interaction with a computer or tablet interface. Not all patients in post-acute care can engage with digital games
- Assessments typically take 15–20 minutes per session, limiting throughput in high-volume care settings
- Primarily established in clinical trial settings. Based on available information, clinical care deployment in post-acute and long-term care is limited compared to research use
- No speech biomarker analysis. Cognitive data comes from task performance, not from the patient’s voice or natural conversation
- No computer vision or visual biomarker capture during assessment
- Game-based testing introduces performance anxiety and practice effects that can influence results
- Based on available information, does not offer an autonomous patient-facing conversational interface for clinical screening
What GIA™ does differently
- Natural conversation replaces game-based testing. Patients speak. GIA™ listens and analyzes.
- Under 5 minutes vs. 15–20 minutes for game-based cognitive assessment
- Screens 46 conditions across cognitive, behavioral, and neurological health in a single session
- Multimodal: Voice AI, Computer Vision, and 2,500+ Speech Biomarkers analyzed simultaneously
- No test anxiety or practice effects. The patient is having a conversation, not taking a test
- Fully autonomous Digital Human®. Zero clinical staff required during the screening
- Built for clinical care deployment in post-acute and long-term care, not primarily for clinical trials
- Real-time EHR write-back of results, medical notes, transcript, and patient video
Cogstate measures cognitive performance through game-based tasks designed for clinical trials. GIA™ screens for 46 conditions through natural conversation designed for clinical care. One requires 15–20 minutes, a tablet, and patient ability to interact with digital games. The other requires under 5 minutes, a conversation, and nothing else. For post-acute and long-term care facilities that need comprehensive screening at scale, the question is not whether Cogstate’s cognitive games are accurate. The question is whether cognitive-only, game-based testing is enough.
Common questions
How is GIA™ different from Cogstate?
GIA™ screens for 46 conditions using natural conversation, Voice AI, Computer Vision, and 2,500+ Speech Biomarkers in under 5 minutes. Cogstate offers game-based computerized cognitive assessment that typically takes 15–20 minutes and focuses on cognitive domains only.
Is Cogstate used in clinical care or just clinical trials?
Cogstate is primarily established in clinical trial settings, providing standardized cognitive endpoints for pharmaceutical research. Based on available information, their clinical care deployment exists but is less established than their research presence. GIA™ is purpose-built for clinical care in post-acute and long-term care facilities.
Why does conversation-based screening matter vs. game-based testing?
Game-based testing requires patients to understand and interact with digital interfaces, which can be challenging for older adults or those with motor impairments. It also introduces practice effects and test anxiety. Conversation-based screening through GIA™ requires only natural speech, works via video, voice, or landline, and captures biomarkers from how a patient speaks, not how they perform on a game.
Does Cogstate screen for depression or Parkinson’s?
Cogstate focuses on cognitive domains including attention, learning, working memory, and psychomotor speed. It does not screen for depression, anxiety, PTSD, Parkinson’s, substance abuse, or other behavioral and neurological conditions. GIA™ screens for 46 conditions across all these categories.
Can GIA™ be used in clinical trials like Cogstate?
GIA™ is currently focused on clinical care deployment in post-acute and long-term care settings. Its speech biomarker data and longitudinal tracking capabilities may support clinical research applications, but its primary deployment is in clinical care, not clinical trial endpoint measurement.
Which is faster, Cogstate or GIA™?
GIA™ screens for 46 conditions in under 5 minutes. Cogstate cognitive assessments typically take 15–20 minutes and cover cognitive domains only. GIA™ delivers results to the clinician in 60 seconds for review.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.